While increased p53 levels in these lesions likely resulted from mutations in the p53 protein, determining whether the specific mutations leading to p53 accumulation directly contribute to neoplasia in schistosomal bladder lesions, e.g., ascertaining whether the mutation is a “passenger” vs. “driver” mutation [described in (42)], will require further investigation. This evidence concerns the gene TP53 and neoplasm.